[1]
|
中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 中华医学会全科医学分会, 中华医学会《中华全科医师杂志》编辑委员会, 消化系统疾病基层诊疗指南编写专家组. 药物性肝损伤基层诊疗指南(2019年) [J]. 中华全科医师杂志, 2020, 19(10): 868-875.
|
[2]
|
Yao, K.Y., Zhang, S.Q., Jin, R., et al. (2023) Comparative Study on Date Set of Drug-Induced Liver Injury. Chinese Journal of Pharmacovigilance, 20, 568-573.
|
[3]
|
Li, X., Tang, J. and Mao, Y. (2022) Incidence and Risk Factors of Drug-Induced Liver Injury. Liver International, 42, 1999-2014. https://doi.org/10.1111/liv.15262
|
[4]
|
沈弢, 黄昕, 王誉雅, 庄辉. 我国药物性肝损伤流行病学研究现状[J]. 临床肝胆病杂志, 2018, 34(6): 1152-1155.
|
[5]
|
Shen, T., Liu, Y., Shang, J., et al. (2019) Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology, 156, 2230-2241. https://doi.org/10.1053/j.gastro.2019.02.002
|
[6]
|
Sgro, C., Clinard, F., Ouazir, K., et al. (2002) Incidence of Drug-Induced Hepatic Injuries: A French Population-Based Study. Hepatology, 36, 451-455. https://doi.org/10.1053/jhep.2002.34857
|
[7]
|
Björnsson, E.S., Bergmann, O.M., Björnsson, H.K., et al. (2013) In-cidence, Presentation, and Outcomes in Patients with Drug-Induced Liver Injury in the General Population of Iceland. Gastroenterology, 144, 1419-1425.E3.
https://doi.org/10.1053/j.gastro.2013.02.006
|
[8]
|
Abajo, F.J.D., Montero, D., Madurga, M. and García Rodríguez, L.A. (2015) Acute and Clinically Relevant Drug-Induced Liver Injury: A Population Based Case-Control Study. British Journal of Clinical Pharmacology, 58, 71-80.
https://doi.org/10.1111/j.1365-2125.2004.02133.x
|
[9]
|
Vega, M., Verma, M., Beswick, D., et al. (2017) The Inci-dence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterolo-gist-Based Surveillance in the Population of the State of Delaware. Drug Safety, 40, 783-787. https://doi.org/10.1007/s40264-017-0547-9
|
[10]
|
刘玉兰, 王晶桐. 老年人药物性肝损害的诊治[J]. 中华老年医学杂志, 2009, 28(4): 274-275.
|
[11]
|
Mitchell, S.J. and Hilmer, S.N. (2010) Drug-Induced Liver Injury in Older Adults. Therapeutic Advances in Drug Safety, 1, 65-77. https://doi.org/10.1177/2042098610386281
|
[12]
|
袁玲, 杨永耿, 马颖才. 老年人药物性肝损伤临床特点分析[J]. 肝脏, 2021, 26(4): 442-443, 463.
|
[13]
|
李亚飞, 闫华楠, 韩少静, 郭永泽, 韩书香, 李淑霞, 吉丽, 张宏伟. 老年急性药物性肝损伤临床特征及预后影响因素分析[J]. 肝脏, 2020, 25(3): 319-322.
|
[14]
|
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志, 2015, 23(11): 810-820.
|
[15]
|
中华中医药学会肝胆病分会, 中华中医药学会中成药分会. 中草药相关肝损伤临床诊疗指南[J]. 中国中药杂志, 2016, 41(7): 1165-1172.
|
[16]
|
European Association for the Study of the Liver (2019) EASL Clinical Practice Guide Lines: Drug-Induced Liver Injury. Journal of Hepatology, 70, 1222-1261. https://doi.org/10.1016/j.jhep.2019.02.014
|
[17]
|
王丽苹, 何婷婷, 崔延飞, 等. 解放军总医院第五医学中心2009年-2019年老年药物性肝损伤患者的临床特征及变化趋势[J]. 临床肝胆病杂志, 2020, 36(10): 2248-2252.
|
[18]
|
Council for International Organizations of Medical Sciences (CIOMS) (2020) Drug-Induced Liver In-jury(DILI): Current Status and Future Directions for Drug Development and the Post-Market Setting. A Consensus by a CIOMS Working Group. Geneva.
|
[19]
|
任慧琼, 姚均迪, 赵红信, 等. 基于RUCAM评估量表的高龄老年药物性肝损伤162例临床分析[J]. 肝脏, 2021, 26(11): 1276-1278.
|
[20]
|
杨雪, 涂荣芳, 杨晋辉. 498例药物性肝损伤患者的临床特点及其预后分析[J]. 中华肝脏病杂志, 2022, 30(7): 735-740.
|
[21]
|
郭甜甜, 马子坤, 王昱, 等. 老年药物性肝损伤的临床特征及预后分析[J]. 药物不良反应杂志, 2023, 25(6): 345-351.
|
[22]
|
张平, 柯玉满, 樊小春, 等. 药物性肝损伤临床分析324例[J]. 世界华人消化杂志, 2013, 21(33): 3720-3723.
|
[23]
|
Chalasani, N., Bonkovsky, H.L., Fontana, R., et al. (2015) Features and Outcomes of 899 Patients with Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology, 148, 1340-1352.
https://doi.org/10.1053/j.gastro.2015.03.006
|
[24]
|
Lucena, M.I., et al. (2009) Phenotypic Characterization of Idio-syncratic Drug-Induced Liver Injury: The Influence of Age and Sex. Hepatology, 49, 2001-2009. https://doi.org/10.1002/hep.22895
|
[25]
|
Reuben, A., Koch, D.G. and Lee, W.M. (2010) Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study. Hepatology, 52, 2065-2076. https://doi.org/10.1002/hep.23937
|
[26]
|
Hoofnagle, J.H. and Björnsson, E.S. (2019) Drug-Induced Liver Injury: Types and Phenotypes. The New England Journal of Medicine, 381, 264-273. https://doi.org/10.1056/NEJMra1816149
|
[27]
|
O’donohue, J., Oien, K.A., Donaldson, P., et al. (2000) Co-Amoxiclav Jaundice: Clinical and Histological Features and HLA Class II Association. Gut, 47, 717-720. https://doi.org/10.1136/gut.47.5.717
|
[28]
|
Donaldson, P.T., Daly, A.K., Henderson, J., et al. (2010) Human Leu-cocyte Antigen Class II Genotype in Susceptibility and Resistance to Co-Amoxiclav-Induced Liver Injury. Journal of Hepatology, 53, 1049-1053.
https://doi.org/10.1016/j.jhep.2010.05.033
|
[29]
|
Li, C.P., Rao, T., Chen, X.P., et al. (2019) HLA-B*35: 01 Allele Is a Potential Biomarker for Predicting Polygonum Multiflorum-Induced Liver Injury in Humans. Hepatology, 70, 346-357. https://doi.org/10.1002/hep.30660
|
[30]
|
Hunt, C.M., Yuen, N.A., Stirnadel-Farrant, H.A. and Suzuki, A. (2014) Age-Related Differences in Reporting of Drug-Associated Liver Injury: Data-Mining of WHO Safety Report Database. Regulatory Toxicology and Pharmacology, 70, 519-526. https://doi.org/10.1016/j.yrtph.2014.09.007
|
[31]
|
丁惠国. 重视老年人药物性肝损伤[J]. 药物不良反应杂志, 2014(3): 132-133.
|
[32]
|
崔金英. 老年人常见药物性肝损伤研究进展[J]. 中国误诊学杂志, 2017(5): 116-118.
|
[33]
|
赵欢, 刘建秋, 薛鹏. 石家庄社区老年多重用药患者生命质量及其影响因素[J]. 中国老年医学杂志, 2013, 33(5): 1137-1139.
|
[34]
|
Tulner, L.R., Kuper, I.M., Frankfort, S.V., et al. (2009) Discrepancies in Reported Drug Use in Geriatric Outpatients: Relevance to Adverse Events and Drug-Drug In-teractions. The American Journal of Geriatric Pharmacotherapy, 7, 93-104. https://doi.org/10.1016/j.amjopharm.2009.04.006
|
[35]
|
Juniius-Walker, U., Theile, G. and Hummers-Pradier, E. (2007) Prevalence and Predictors of Polypharmacy among Older Primary Care Patients in Germany. Family Practice, 24, 14-19. https://doi.org/10.1093/fampra/cml067
|
[36]
|
Kong, X., Guo, D., Liu, S., Zhu, Y. and Yu, C.X. (2021) Inci-dence, Characteristics and Risk Factors for Drug-Induced Liver Injury in Hospitalized Patients: A Matched Case-Control Study. British Journal of Clinical Pharmacology, 87, 4304-4312. https://doi.org/10.1111/bcp.14847
|
[37]
|
Weersink, R.A., Alvarez-Alvarez, I., Medina-Cáliz, I., et al. (2021) Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old. Clinical Pharmacology & Therapeutics, 109, 1147-1158. https://doi.org/10.1002/cpt.2108
|
[38]
|
Byeon, J.H., Kil, J.H., Ahn, Y.C. and Son, C.G. (2019) Systematic Review of Published Data on Herb Induced Liver Injury. Journal of Ethnopharmacology, 233, 190-196. https://doi.org/10.1016/j.jep.2019.01.006
|
[39]
|
姬琛华, 张竹青, 王晓媛, 卢书明. 老年药物性肝损伤患者临床特征分析[J]. 临床肝胆病杂志, 2017(3): 502-506.
|
[40]
|
彭朋, 元唯安. 中药药源性肝毒性的研究进展[J]. 药物评价研究, 2021, 44(8): 1783-1792.
|
[41]
|
He, S., Zhang, C., Zhou, P., et al. (2019) Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis. International Journal of Molecular Sciences, 20, Article 3633.
https://doi.org/10.3390/ijms20153633
|
[42]
|
蒋美纯, 朱萱. 他汀类药物治疗慢性肝病有效性及安全性研究进展[J]. 中国实用内科杂志, 2020, 40(5): 423-427.
|
[43]
|
陆玮婷, 李军, 欧宁, 等. 276例药物性肝损伤的病因和临床表现分析[J]. 中华肝脏病杂志, 2006, 14(11): 832-834.
|
[44]
|
王亚南. 药物性肝损伤78例临床分析[J]. 青岛医药卫生, 2022, 54(5): 325-329.
|